KL *VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE *4 carriers. Belloy ME, Eger SJ, Le Guen Y, Napolioni V, et al. Neurobiol Aging 2021;101:123-129.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Belloy ME, Eger SJ, Le Guen Y, Napolioni V, et al. KL *VS heterozygosity reduces brain amyloid in asymptomatic at-risk APOE *4 carriers. Neurobiol Aging 2021;101:123-129.
PMID: 33610961